Navigation Links
STAAR Surgical Reports Progress on Japan Application for Approval of Visian Toric Implantable Collamer® Lens (TICL)
Date:10/19/2011

s and markets lenses in approximately 50 countries.  Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA.  For more information, please visit the Company's website at www.staar.com or call 626-303-7902.  

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material.

Safe HarborAll statements in this press release that are not statements of historical fact are forward-looking statements, including any statements about the approval of pending regulatory applications, the potential effect of new product approvals on our business, any statements of belief and any statements of assumptions underlying any of the foregoing.

These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The risks and uncertainties include the following: the effect of poor global economic conditions on sales, especially sales of products like the ICL used in non-reimbursed elective procedures; our limited resources to promote new products; the discretion of regulatory agencies to approve or reject new products, or to require additional actions before approval, the risk that product launches may be affected by unplanned delays or be less successful than we expect; the willingness of surgeons and patients to adopt a new product and procedure; the entrenched market position of laser-based procedures for many conditions treated by the Visian ICL; and patterns of Visian ICL use that have typically limited our penetration of the refractive surgery market. STAAR assumes no obligation to update its forward-looking statements to reflect future events or actual outcomes and does
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. STAAR Surgical to Present at the 2011 Canaccord Genuity Growth Conference
2. STAAR Surgical Reports 19% Revenue Growth Second Quarter
3. STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000
4. STAAR Surgicals nanoFLEX™ Collamer® IOL Receives CE Mark Approval
5. STAAR Surgical Launches Second Phase of Visian ICL Direct-to-Consumer Advertising Campaign
6. STAAR Surgical Enters Into Distribution Agreement With Ellex in Australia
7. STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million
8. STAAR Surgicals Visian® ICL Surpasses 200,000 Implants
9. STAAR Surgical Reports Continued Double Digit Core Revenue Growth
10. STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS
11. STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for ... announced that it will release Second Quarter financial ... 2015. AcelRx management will host an investment-community conference ... Pacific Time) on Aug 3rd, 2015 to discuss ...
(Date:7/29/2015)... Calif. , July 29, 2015  Efforts to ... growth strategy of pharmaceutical firms in North ... The realization is that an effective working capital management ... pressures and patent cliffs. Big pharma companies expect to ... Logo - http://photos.prnewswire.com/prnh/20150724/241957LOGO ...
(Date:7/29/2015)... July 29, 2015 Legal-Bay LLC, The Lawsuit Settlement ... Goodwin in the Southern District of West ... trial that was initially set to start in November. The ... but new plaintiffs were added and now it involves 39 ... 7 th , according to an article in Reuters. The ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 3AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 4Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3
... landscape for new pharmaceutical products has shifted dramatically, with ... changes facing launch teams. At the same time, the ... with the pharmaceutical industry facing pipeline deficits, patent expirations ... new launch environment, Best Practices, LLC has developed the ...
... 30, 2012  Molecular Detection Inc. (MDI), a company developing ... of infectious disease diagnosis, today announced it will release ... the 22nd European Congress of Clinical Microbiology and Infectious ... Panel has been further enhanced by increasing the number ...
Cached Medicine Technology:Excellence Services Program Helps Guide Pharmaceutical Industry Through the New Product Launch Landscape 2Molecular Detection Inc. Launches Improved Version of Detect-Ready® MRSA Panel at 2012 ECCMID Congress 2Molecular Detection Inc. Launches Improved Version of Detect-Ready® MRSA Panel at 2012 ECCMID Congress 3
(Date:7/29/2015)... ... ... privileged to announce that U.S. News & World Report has ranked the USC ... nation for 2015-2016. This marks the 21st consecutive year that the USC Eye Institute has ... to be included in the top 10 ophthalmology hospitals by U.S. News & World Report,” ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired by a successful teaching ... W. Meier M.D., a prominent orthopedic surgeon and regenerative medicine expert in Beverly ... need. , “We are thrilled for this opportunity to offer prolotherapy treatments for ...
(Date:7/29/2015)... ... 2015 , ... Stealth Therapeutics Inc. announced today that it ... Invisiport at Wheaton Franciscan Healthcare in Milwaukee, Wis. The Invisiport product line, which ... alternative to traditional chest ports and peripherally inserted central catheters (PICCs). It is ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... decision from the Judicial Panel on Multidistrict Litigation (JPML), according to court documents.* ... research at their website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, the ...
(Date:7/29/2015)... ... 2015 , ... The Woodlands and Spring Fit Body Boot Camps have implemented ... causes each month. The new system will track each time a client uses social ... each facility, the boot camps will donate 20 cents to a selected charity. , ...
Breaking Medicine News(10 mins):Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3
... of a certain cell in the immune system may help ... the Program in Cellular and Molecular Medicine and the Immune ... 21 in Nature Immunology , they show, for the ... cells (DCs) capture flu viruses and show them to B-lymphocytes, ...
... provide target for future treatments, researchers say , MONDAY, ... variations linked with an increased risk for lung cancer ... research team analyzed DNA from more than 1,000 people ... smoked and found strong evidence that two variations in ...
... ... ... ... /PRNewswire/ - Haemacure Corporation (TSX:HAE) announces that it has obtained authorization from the Superior Court of the Province of Québec to sell its assets to Angiotech Pharmaceuticals, Inc., a ...
... MAYO Communications has been retained to promote the first MAMMOJAM 2010 set for Thursday, April 1, 2010 , at the newly opened Rise Club , 6801 W. Hollywood Blvd., ... , ... ... ...
... ... innovator in the live archiving space, MessageSolution is the first on-premise and SaaS archiving ... including Exchange, Domino GroupWise, file systems and SharePoint, delivering compliance archiving for all Unix/Linux-based ... ...
... ... surgery in Honolulu, Hawaii , is unveiling a new, interactive website geared toward educating web ... ... suffer from morbid obesity, weighing 80 pounds or more over the average for their size ...
Cached Medicine News:Health News:Poorly understood cell plays role in immunity against the flu 2Health News:Poorly understood cell plays role in immunity against the flu 3Health News:Court Authorizes Haemacure to Sell its Assets and Grants a Second Extension to Make a Proposal to its Creditors 2Health News:MAYO Communications Retained by MAMMOJAM 2010 Dr. Susan Love Research Foundation Event 2Health News:MAYO Communications Retained by MAMMOJAM 2010 Dr. Susan Love Research Foundation Event 3Health News:MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010 2Health News:MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010 3Health News:MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010 4Health News:MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010 5Health News:MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010 6Health News:Honolulu, Hawaii Bariatric Surgery Practice Launches New Website to Reach Out to Patients Fighting Morbid Obesity 2Health News:Honolulu, Hawaii Bariatric Surgery Practice Launches New Website to Reach Out to Patients Fighting Morbid Obesity 3
... Since its introduction to the market, the ... has proven itself as a highly efficient ... fields of urology and gastroenterology. The new ... been technically further developed and improved in ...
ELVeS™ (Endo Laser Vein System) from biolitec is a versatile, easy to use & complete system that allows you to treat all conditions resulting from venous incompetence. (ELVeS has FDA clearance ...
One piece, 100% fused silica construction offers low scatter and high efficiency...
The new series of Steris Power-lift Stirrups incorporate all of the proven clinical benefits of Allen-style booted stirrups: maximum safety for the patient, ease of setup for your staff, impressive v...
Medicine Products: